Scantox Group
Mette Ellemann-Søtofte is an experienced professional in the pharmaceutical and biotech sectors, currently serving as the Chief Operating Officer at Scantox since January 2021. Prior to this role, Mette held the position of Director at Charles River Laboratories and various leadership roles at Novo Nordisk A/S, including Team Leader for Clinical Supplies Project Planning. Mette's career began at CiToxLAB Scantox, where significant responsibilities included establishing the pharmacokinetic area and managing pre-clinical studies. Mette's background also includes work as a Research Scientist at LEO Pharma. Mette holds an M.Sc. in Pharmacy from the Danish University of Pharmaceutical Sciences and a Diploma in Laboratory Animal Science from The Royal Veterinary and Agricultural University.
Scantox Group
Scantox is a contract research organization that specializing in pharmacology and regulatory toxicology services. Their preclinical contract research services enable clients to progress their drug or device development. They offer various contract research services such as safety pharmacology, exploratory, and endotoxin testing.